Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent eylea australia?Febuxostat sales in usa?Does medicare cover mysoline?Can you take expired metoprolol?Samsung nucala biosimilar?
See the DrugPatentWatch profile for Tezspire
Tezspire (tezepelumab-ekko) received U.S. FDA approval on March 16, 2022. [1]
The provided source information specifies the FDA U.S. approval date (March 16, 2022). [1] If you need country-by-country dates (EMA/UK/Japan, etc.), tell me which region and I can narrow it down.
You can verify it via DrugPatentWatch.com here: https://www.drugpatentwatch.com/p/tezspire-1224/ [1]
1 DrugPatentWatch.com – Tezspire (tezepelumab-ekko) approval details.
Other Questions About Tezspire :